Raia Drogasil S.A. (OTCMKTS: RADLY) is a leading Brazilian retail pharmacy chain focused on the distribution and sale of pharmaceutical products, over-the-counter medicines, cosmetics, personal care items and wellness goods. Headquartered in São Paulo, the company serves a broad consumer base through a network of more than 2,400 stores located across all regions of Brazil. In addition to its brick-and-mortar operations, Raia Drogasil offers digital services, including online prescription fulfillment and home delivery, enabling customers to access its product portfolio through multiple channels.
The company’s core business activities encompass retail pharmacy operations, supply-chain logistics and distribution, private-label manufacturing and commercial partnerships with pharmaceutical laboratories. Raia Drogasil integrates store operations with advanced inventory management systems and regional distribution centers to maintain high product availability, support rapid replenishment and ensure regulatory compliance with Brazilian health authorities. Its private-label brands and loyalty programs are designed to enhance customer retention and differentiate its product offering in a competitive marketplace.
Raia Drogasil traces its origins to the merger of two historic pharmacy chains, Farmácias Raia and Drogasil, in 2011. The combined entity has since grown through strategic acquisitions and organic expansion, solidifying its position as Brazil’s largest drugstore operator. The company is governed by an executive board with extensive experience in retail, healthcare and supply-chain management. As a publicly traded company on both the B3 exchange (RADL3) and the OTC market (RADLY), Raia Drogasil adheres to rigorous corporate governance standards and regularly publishes operational and sustainability reports to inform investors and stakeholders.
AI Generated. May Contain Errors.